Metastatic Solid Cancer Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to GM-CSF
Related studies linked through entity extraction aliases.
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium
- Status
- UNKNOWN
- Phase
- NA
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
- Status
- TERMINATED
- Phase
- PHASE2
GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study
- Status
- COMPLETED
- Phase
- PHASE4
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699
- Status
- TERMINATED
- Phase
- PHASE1
Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis
- Status
- UNKNOWN
- Phase
- PHASE2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- Status
- COMPLETED
- Phase
- PHASE2
REO13 Melanoma With of Without GM-CSF
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Chemoimmunotherapy for High-Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
- Status
- UNKNOWN
- Phase
- PHASE4
Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)
- Status
- COMPLETED
- Phase
- PHASE2